Kevin Lind
KL
Kevin Lind
CEO
Rate
About
Kevin Lind is an experienced biopharmaceutical executive who currently serves as the CEO of Apnimed. He previously co-founded Longboard Pharmaceuticals and served as its President and CEO through its $2.6 billion acquisition by H. Lundbeck A/S.
Frequently asked
Who is Kevin Lind?
Kevin Lind is an experienced biopharmaceutical executive who currently serves as the CEO of Apnimed. He previously co-founded Longboard Pharmaceuticals and served as its President and CEO through its $2.6 billion acquisition by H. Lundbeck A/S.
What is Kevin Lind's current role?
Kevin Lind is currently CEO.
Comments
No comments yet. Be the first to share your take.
Profile
About Kevin Lind
Kevin Lind is CEO. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.